ClinVar Miner

Submissions for variant NM_001370259.2(MEN1):c.950A>G (p.His317Arg)

dbSNP: rs1114167495
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000491775 SCV000579677 likely pathogenic Hereditary cancer-predisposing syndrome 2024-09-09 criteria provided, single submitter clinical testing The p.H317R variant (also known as c.950A>G), located in coding exon 6 of the MEN1 gene, results from an A to G substitution at nucleotide position 950. The histidine at codon 317 is replaced by arginine, an amino acid with highly similar properties. This alteration was observed in a proband suspected of having MEN1 with a history of hyperparathyroidism and a carcinoid tumor (Roijers, JF et al. Eur J Clin Invest. 2000 Jun;30(6):487-92). This mutation was also identified in a MEN1 family with at least two affected individuals with a history of primary hyperparathyroidism and/or carcinoid tumors (Wautot, V et al. Hum Mutat. 2002 Jul;20(1):35-47). Of note, this alteration is also designated as c.1060A>G in published literature. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.